Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Muhammad Rauzan"'
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0174107 (2017)
Chronic myeloid leukemia (CML) treatment has been improved by tyrosine kinase inhibitors (TKIs) such as imatinib mesylate (IM) but various factors can cause TKI resistance in patients with CML. One factor which contributes to TKI resistance is a germ
Externí odkaz:
https://doaj.org/article/333aea2122484f3baab98c46f3c10f53
Autor:
Muhammad Rauzan, Fitriani Yulianti
Publikováno v:
Jurnal Pendidikan Geosfer. 7:105-113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a54aa6dbf32c8750b3f3e2eb1bdc242
https://doi.org/10.24815/jpg.v7i1.24400
https://doi.org/10.24815/jpg.v7i1.24400
Publikováno v:
Jurnal Ilmiah Mahasiswa Pertanian. 1:353-368
Kemiskinan dalam kehidupan manusia pada belahan dunia manapun senantiasa tidak terlepas dari kebutuhan hidup dan strategi bertahan hidup, baik masyarakat perkotaan maupun masyarakat yang tinggal dipedesaan. Strategi kelangsungan hidup bagi masyarakat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::905ffb5432ac6c52a4d6c9900e76c30f
https://doi.org/10.17969/jimfp.v1i1.1329
https://doi.org/10.17969/jimfp.v1i1.1329
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0174107 (2017)
PLoS ONE
PLoS ONE
Chronic myeloid leukemia (CML) treatment has been improved by tyrosine kinase inhibitors (TKIs) such as imatinib mesylate (IM) but various factors can cause TKI resistance in patients with CML. One factor which contributes to TKI resistance is a germ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8036494e2ba38a398a3594f5f12dcc5
http://europepmc.org/articles/PMC5354438?pdf=render
http://europepmc.org/articles/PMC5354438?pdf=render